These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1549991)

  • 1. Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. PRIMI Study Group.
    Schofer J; Ress-Grigolo G; Voigt KD; Mathey DG
    Am Heart J; 1992 Apr; 123(4 Pt 1):846-53. PubMed ID: 1549991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
    Tanasijevic MJ; Cannon CP; Antman EM; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Braunwald E
    J Am Coll Cardiol; 1999 Sep; 34(3):739-47. PubMed ID: 10483955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion.
    Laperche T; Steg PG; Benessiano J; Dehoux M; Juliard JM; Himbert D; Gourgon R
    Am J Cardiol; 1992 Nov; 70(13):1129-34. PubMed ID: 1414933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Steg PG; Dehoux M; Benessiano J; Grollier G; Aliot E; Mossard JM; Aubry P; Coisne D; Hanssen M
    Circulation; 1995 Oct; 92(8):2079-86. PubMed ID: 7554185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.
    Norris RM; White HD; Cross DB; Woo KS; Elliott JM; Twigden D; Williams B; Johnson RN
    Br Heart J; 1993 Jun; 69(6):485-91. PubMed ID: 8343313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase.
    Norris RM; Twigden DG; Williams BF; Johnson RN; White HD
    Coron Artery Dis; 1993 Feb; 4(2):201-5. PubMed ID: 8269212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis.
    Zabel M; Hohnloser SH; Köster W; Prinz M; Kasper W; Just H
    Circulation; 1993 May; 87(5):1542-50. PubMed ID: 8491009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction. The PRIMI Trial Study Group.
    Schofer J; Lins M; Mathey DG; Sheehan FH
    Eur Heart J; 1993 Jul; 14(7):958-63. PubMed ID: 8375422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study.
    Timmis AD; Griffin B; Crick JC; Nelson DJ; Sowton E
    Br Heart J; 1987 Oct; 58(4):345-51. PubMed ID: 3314951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.
    Karagounis L; Sorensen SG; Menlove RL; Moreno F; Anderson JL
    J Am Coll Cardiol; 1992 Jan; 19(1):1-10. PubMed ID: 1729317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS).
    Relik-van Wely L; Visser RF; van der Pol JM; Bartholomeus I; Couvée JE; Drost H; Vet AJ; Klomps HC; van Ekelen WA; van den Berg F
    Am J Cardiol; 1991 Aug; 68(4):296-300. PubMed ID: 1858670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
    de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
    Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction.
    Norris RM; White HD; Cross DB; Woo KS; Maslowski AH; Caruana MP; Hart HH; Williams B
    Br Heart J; 1993 Jun; 69(6):492-5. PubMed ID: 8343314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
    Christenson RH; Ohman EM; Topol EJ; Peck S; Newby LK; Duh SH; Kereiakes DJ; Worley SJ; Alosozana GL; Wall TC; Califf RM
    Circulation; 1997 Sep; 96(6):1776-82. PubMed ID: 9323061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.